skip to Main Content

Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2

Newsfeed image, light gray text on dark gray background
Germline mutations in BRCA1/2 are risk factors for pancreatic ductal adenocarcinoma (PDAC).

The aim of this study was to evaluate whether results of surveillance for PDAC in high-risk individuals (HRI) differ between those with and without a pathogenic BRCA1/2 mutation. This prospective study was conducted within the Pancreatic Tumor Registry at a major cancer center. Read more . . .

Back To Top